A Happy New EMLitOfNote Year!

Hello, New York City!  You win – with a commanding lead, 4.4% of all visitors to the site, over the past year.  But, after NYC, you have to go down to #5 to get to another U.S. city, and only 4 of the top 10 are ‘merican:

• New York
• Sydney
• Melbourne
• London
• Chicago
• Houston
• Brisbane
• Philadelphia
• Perth
• Toronto

Australia, I love you too.

What were some of the top posts of the past year?

Pre-Hospital Furosemide – No, No, Also No
It’s almost certainly net harmful for paramedics to give furosemide in the pre-hospital setting.

TMJ Dislocations: A Better Mousetrap?
The syringe technique for relocating mandible dislocations.  Cool.

The Scandal of Dabigatran – A Summary
Unless you’ve been living under a rock, you know we’ve been lied to about Pradaxa.

Azithromycin, the World’s Most Effective Antiviral
What’s more insane than one mostly useless treatment for influenza?  Trying to prove the value in adding an antimicrobial to the mix.

Go Ahead, Age-Adjust the D-Dimer
If you’re going to use D-Dimer to rule-out PE, you probably won’t miss much if you use higher cut-offs in the elderly.

The tPA Cochrane Review Takes Us For Fools
The updated tPA Cochrane Review is just another biased document failing to acknowledge the limitations of the underlying data.

My ACEP tPA Policy Critique
The ACEP Clinical Policy regarding use of tPA was controversial, to put it mildly.

Bayesian Statistics: We’re Dumb as Rocks
How many patients have a disease with prevalence 1/1000, given a test with 5% false positives?  Banana.

Of course, a few great posts from the past couple months simply haven’t had enough of an internet lifetime to accumulate pageviews, including Jerry Hoffman Debates Greg Albers on tPA, the ARISE study, and MR-CLEAN.

Also, a special thanks to Anand Swaminathan, Rory Spiegel, and William Paolo for their guest posts this year.

Thanks for visiting!  I hope you enjoy keeping up and poking holes in the newly published literature as much as I do in 2015!